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Abstract 
Expanding human chondrocytes in vitro while maintaining their ability to form cartilage 
remains a key challenge in cartilage tissue engineering. One promising approach to address 
this is to use microcarriers as substrates for chondrocyte expansion. While microcarriers have 
shown beneficial effects for expansion of animal and ectopic human chondrocytes, their 
utility has not been determined for freshly-isolated adult human articular chondrocytes. Thus, 
we investigated the proliferation and subsequent chondrogenic differentiation of these 
clinically relevant cells on porous gelatin microcarriers and compared them to those expanded 
using traditional monolayers. Chondrocytes attached to microcarriers within 2 days and 
remained viable over 4 weeks of culture in spinner flasks. Cells on microcarriers exhibited a 
spread morphology and initially proliferated faster than cells in monolayer culture, however, 
with prolonged expansion they were less proliferative. Cells expanded for one month and 
enzymatically released from microcarriers formed cartilaginous tissue in micromass pellet 
cultures, which was similar to tissue formed by monolayer-expanded cells. Cells left attached 
to microcarriers did not exhibit chondrogenic capacity. Culture conditions, such as 
microcarrier material, oxygen tension, and mechanical stimulation require further 
investigation to facilitate the efficient expansion of clinically relevant human articular 
chondrocytes that maintain chondrogenic potential for cartilage regeneration applications. 
Keywords: Cartilage, tissue engineering, microcarrier, chondrocyte, dedifferentiation  
Introduction 
Articular cartilage is avascular and exhibits limited intrinsic regenerative capacity when 
damaged (1). Tissue engineering offers an attractive approach for cartilage repair through the 
combined use of chondrogenic cells with biomaterials and environmental factors that support 
the de novo formation of cartilage in situ (2). However, the development of tissue-engineered 
grafts of clinically relevant sizes remains challenging. In order to obtain an adequate number 
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of cells from typically small cartilage biopsies, substantial expansion of cells is required. 
Confounding this, chondrocytes from clinically relevant aged donors, show decreased 
proliferation in vitro (3). In addition, during ex vivo expansion chondrocytes rapidly lose their 
chondrogenic state (dedifferentiation) and express a fibroblastic phenotype with decreased 
expression of chondrocyte proteins, such as aggrecan and type II collagen, and an increase in 
the production of fibroblast proteins, namely collagen type I (4, 5). 
The use of microcarriers for chondrocyte expansion has been investigated to overcome some 
of these effects (6-10). Microcarrier culture offers a cost-efficient method of propagating large 
populations of cells due to a high surface area to volume ratio (10). In addition, microcarriers 
may be cultured in bioreactors which allow critical biological and chemical factors (pH, pO2, 
and metabolites), as well as physical factors (such as shear), to be monitored and precisely 
controlled. In particular, porous collagen-derived microcarriers have been shown to benefit 
the expansion of bovine articular chondrocytes (7, 8) and enhance the chondrogenic potential 
of human nasoseptal chondrocytes (6). However, these cells are dissimilar to human articular 
chondrocytes (11-13), thus it remains unclear if expansion on gelatin microcarriers improves 
the chondrogenic potential of clinically relevant adult human articular chondrocytes.  
Microcarriers also have the dual potential to act as an expansion surface that does not require 
enzymatic harvesting and a scaffold for differentiation. For example, epidermal and dermal 
cell-seeded microcarriers enhanced skin healing (14, 15) and hepatocyte-seeded microcarriers 
have been shown to restore liver function in rats (16). Microcarrier-cultivated porcine 
chondrocytes implanted into full-thickness porcine cartilage defects outperformed 
chondrocytes propagated in monolayers (17). However, the putative advantage of leaving 
these cells on microcarriers during differentiation remains to be confirmed. 
In this study, freshly isolated adult human articular chondrocytes were expanded using 
porous, gelatin-based microcarriers (CultiSpher G). Cell proliferation, production of 
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extracellular matrix, cell viability and phenotype were investigated during expansion on 
microcarriers and conventional tissue-culture plastic. We subsequently evaluated the 
chondrogenic capacity of the cultivated chondrocytes, including those attached to 
microcarriers, in serum-free micromass pellet cultures.  
Materials and methods 
Cell isolation  
Articular cartilage (visually normal, International Cartilage Repair Society anatomical grade 
0-1) was obtained with institutional ethics approval from consenting patients (2 female, 2 
male) undergoing limb amputations or arthroplasties. Cartilage slices were minced, washed in 
phosphate buffered saline (PBS) (Invitrogen, Carlsbad, CA) and digested overnight with 
0.15% w/v collagenase type 2 (Worthington, Lakewood, NJ) in serum-free, low-D-glucose 
(1 g/L) basal medium (Dulbecco’s Modified Eagle Medium (DMEM) with 4 mM L-alanyl-L-
glutamine, 1 mM sodium pyruvate, 10 mM N-(2-hydroxyethyl)piperazine-N′-(2-
ethanesulfonic acid), 0.1 mM non-essential amino acids, 50 U/mL penicillin, 50 μg/mL 
streptomycin (all Invitrogen) and 0.4 mM L-proline (Sigma, St. Louis, MO). 
Cell expansion  
Freshly isolated chondrocytes were propagated either on tissue culture plastic (TCP) or on 
macroporous, highly tortuous CultiSpher G microcarrier beads (Percell, Åstorp, Sweden). 
Based on manufacturer’s information about microcarrier size (130-380 µm) and density (1.04 
g/cm
3
), we calculated the surface area for non-porous spheres and the theoretical number of 
beads per mg dry weight. The arithmetic mean of minimum and maximum values for 
microcarrier surface area was then multiplied by an arbitrary factor of 2 to account for the 
high porosity and rounded up to 0.7 cm
2
/mg dry weight. Cells were maintained in low-
glucose basal medium supplemented with 0.1 mM L-ascorbic acid 2 phosphate trisodium 
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(WAKO Chemical, Osaka, Japan) and 10% fetal bovine serum (FBS) (Hyclone, Logan, UT) 
at 37˚C in a humidified 5% CO2 incubator. Medium was refreshed twice per week. 
For monolayer expansion, cells were seeded at 10
4
 cells*cm
-2
 in tissue culture flasks (Nunc, 
Roskilde, Denmark) or, for microscopic analysis, in glass chamber slides (BD Biosciences, 
Franklin Lakes, NJ). Cells were passaged when subconfluent by washing twice with PBS and 
incubating in 0.25% trypsin with 1 mM ethylenediamine tetraacetic acid (EDTA) (Invitrogen) 
at 37˚C for 5 min. Cells were counted with a NucleoCounter (Chemometec, Allerød, 
Denmark). Chondrocytes were used for differentiation studies after 3 passages.  
For microcarrier expansion, microcarriers were weighed, rehydrated in PBS in spinner flasks 
(Bellco Glass, Vineland, NJ), sterilized by autoclave and then washed twice in PBS and 
resuspended in culture medium (6). Cells were seeded at a density of 10
4
 cells per mg 
microcarrier per mL culture medium and cultivated using the Variomag BIOSYSTEM 4B 
(Thermo Fisher, Waltham, MA) under intermittent stirring at 20 rpm for 30 s every 30 min 
during the first 2 days. The stirring regime was then changed to continuous stirring at 50-
65 rpm for the remainder of culture. Samples from microcarrier cultures were collected twice 
per week for characterization of cell viability, proliferation and matrix deposition. 
Microcarriers with adherent cells were washed twice in PBS and subjected to histological 
staining procedures, or weighed and digested overnight at 60˚C with 0.5 mg/mL proteinase K 
(Invitrogen) in phosphate buffer (PBE) (20 mM Na2HPO4, 30 mM NaH2PO4.H2O, 5 mM 
EDTA, pH 7.1). Cells were harvested from microcarriers by washing twice in PBS and 
incubating in trypsin-EDTA at 37˚C for 10-20 min, until microcarriers were digested. Coarse 
microcarrier debris was removed by passing through a 100 μm cell strainer (BD Biosciences). 
Chondrogenic differentiation  
The chondrogenic capacity of the propagated cells was evaluated using histological and 
biochemical assays after 7, 14 and 21 days of pellet cultivation in serum-free chondrogenic 
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media (basal medium with 1.25 mg/mL bovine serum albumin, 10-
7
 M dexamethasone, 1% 
v/v ITS+1 (all Sigma), 0.1 mM L-ascorbic acid (WAKO) and 10 ng/mL transforming growth 
factor type beta 1 (TGF-β1) (MILLIPORE, Billerica, MA). Cell pellets were formed by 
centrifugation of 5 x 10
5
 cells detached from microcarriers or tissue culture plastic, or cells 
attached to microcarriers at 600 x g in 15 mL Falcon tubes (BD Biosciences). These pellets 
were cultured for up to 21 days and media were refreshed twice per week.  
Quantification of DNA, glycosaminoglycans (GAG) and tritiated proline incorporation 
DNA content was quantified using the CyQUANT® cell proliferation assay (Invitrogen). 
Briefly, proteinase K-digested cell samples were diluted in PBE, transferred into 96-well 
plates (Nunc) and treated with 40 μg/mL RNase A solution (Invitrogen) supplemented with 
180 mM NaCl and 1 mM EDTA. Dye solution was added to the samples and fluorescence 
measured with a micro-plate reader (BMG Labtech, Offenburg, Germany) at 485 nm 
excitation and 520 nm emission. DNA content was calculated using λ phage DNA standards. 
GAG content in proteinase K-digests or conditioned media was measured using 1,9-
dimethylmethylene blue dye (DMMB, Sigma) assay. Absorbance at 525 nm was measured 
using a spectrophotometer (Bio-Rad Laboratories, Hercules, CA), and GAG content was 
calculated from chondroitin sulfate standards (Sigma). 
De novo collagen synthesis in microcarrier cultures was assayed by the incorporation of 
radio-labeled L-proline; an assay which does not discriminate between the different types of 
collagens. Microcarrier cultures were supplemented with 1 μCi/mL L-[5-3H]-proline ([3H]-
pro) (Amersham, Buckinghamshire, UK) over the entire culture period. Proteinase K-digested 
samples were transferred into 96-well plates (Wallac, Turku, Finland) containing 200 μL of 
OptiPhase scintillation cocktail (Fisher, Loughborough, UK). Radioactivity was measured 
with a scintillation counter (Wallac) and expressed as corrected counts per minute (ccpm), 
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with background radioactivity, determined in cell-free microcarrier samples cultured with 
[
3
H]-pro, subtracted from the results. 
Cell viability, metabolic activity and actin filaments 
To characterise cell viability in microcarrier cultures, cell/microcarrier samples were gently 
washed twice in PBS, incubated for 5 min at 37°C in PBS containing 0.67 µg/ml fluorescein 
diacetate (FDA) and 5 µg/ml propidium iodide (PI) (both Invitrogen) and washed again in 
PBS (6). Metabolically active cells were visualized by using a 1 mg/mL 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (6). Phase contrast 
and epi-fluorescence images were captured by a digital camera mounted on an Eclipse TS100 
microscope with T-FL epi-fluorescence attachment (Nikon, Tokyo, Japan). 
For the staining of actin filaments and nuclei, chondrocytes grown on microcarriers or glass 
slides were washed with PBS and fixed and permeated in PBS with 4% w/v formaldehyde 
(Sigma) and 0.4% v/v Triton-X100 (Merck, Darmstadt, Germany) for 30 min. Unreacted 
aldehydes were quenched with 0.1 M glycine (Merck) and the samples were successively 
incubated in 0.8 U/mL rhodamine-labelled phalloidin for 1 h and 2.5 μg/mL 4′,6-diamidino-2-
phenylindole, dihydrochloride (DAPI) (both Invitrogen) for 45 min. Images were captured 
using a confocal laser scanning microscope (Leica, Wetzlar, Germany) by scanning cross-
sections in z-direction in 2 μm increments from 20-100 μm (DAPI: λEX 405 nm, λEM 
460±30 nm; Rhodamine: λEX 561 nm, λEM 655±45 nm). 
Safranin O staining and immunohistochemistry for collagen type I and II 
The expressions of GAG and collagen type I and type II in cell pellet cultures were 
characterized by safranin O staining or immunohistochemistry, respectively. Formalin-fixed 
samples were dehydrated in a graded ethanol series and embedded in paraffin and cut to yield 
~5 m thick cross-sections. Sections were either stained using haematoxylin, fast green FCF 
(0.001% w/v) and safranin O (0.1% w/v) (all Sigma) (18) or probed with antibodies against 
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collagen I or II as follows: After antigen retrieval by applying 0.1% w/v hyaluronidase 
(Sigma) in PBS for 20 min at 37°C and blocking with 2.5% normal horse serum (Vector 
laboratories, Burlingame, CA) for 20 min, sections were incubated with antibodies against 
either collagen type I (1:300, I-8H5, MP Biomedicals, Solon, OH), collagen type II (1:100, II-
II6B3, Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA) or an IgG isotype 
control antibody (mouse IgG, 1:500, Invitrogen) at room temperature in a humidified chamber 
for 1 h. Subsequently, biotinylated secondary anti-rabbit/mouse antibody (Vector) was 
applied to the sections for 30 min, followed by incubation with avidin and biotinylated 
horseradish peroxidase complex reagent (Vector) for 30 min in a humidified chamber. A 5 
min PBS wash was performed after each step. Chromogens were allowed to develop over 5 
min by using ImmPACT™ DAB Substrate (Vector). Samples were rinsed with tap water for 5 
min and counterstained in Gil’s haematoxylin (Sigma). Images were captured with a camera 
(QImaging, Surrey, Canada) mounted on a microscope (Olympus, Tokyo, Japan). 
Statistical analysis 
Statistical analyses were performed using Minitab 15 (Minitab, Inc., PA). Analysis of 
variance (ANOVA) was determined using a general linear model in which donor was 
considered a random effect. If significant differences were detected between conditions, 
Tukey’s post-hoc tests for pair-wise comparisons were performed. Statistically significant 
differences were considered to be present at p<0.05. Correlations between GAG retained in 
cells and matrix of pellets and GAG secreted into media were analyzed by linear regression. 
Results 
Cell expansion in microcarrier cultures 
Chondrocyte viability remained consistently high (>90%) in microcarrier cultures over the 
expansion period, as determined by live-dead assays (Fig 1 D-F). The cells remained 
metabolically active, as revealed by the hydrolysis of MTT (Fig 1 G-I). Isolated cells were 
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initially observed to be randomly distributed over the surfaces of microcarriers (Fig 1 A,D,G) 
and proliferated until the microcarrier surface was completely covered (Fig 1 C,F,I). Although 
cells were initially attached to only some microcarriers, at the end of the culture period almost 
all were covered with cells (Fig 1 I). Cell-microcarrier aggregates tended to form as the cell 
number increased, which demanded increased agitation. Cells on aggregated microcarriers 
developed multiple layers at the junctions between individual beads (Fig 1 C,F). 
Specific staining of actin filaments indicated that chondrocytes dedifferentiated in both the 
monolayer and microcarrier cultures (Fig 2). The phenotype of chondrocytes in monolayer 
cultures (after ~8 population doublings) ranged from spindle-shaped to highly spread forms 
possessing distinct actin bundles suggesting strong adhesion. After 2 weeks in microcarrier 
culture, some cells retained a round chondrogenic phenotype, while other cells had partially 
spread on the porous gelatin matrix of the microcarrier and formed rhodamine-positive 
protrusions resembling lamellipodia(Fig 2).  
Based on DNA content, 73±15% of the seeded cells attached to the microcarriers within the 
first 2 days of culture. Thereafter, the DNA content of chondrocyte microcarrier cultures 
increased exponentially in the first two weeks of cultivation (Fig 3 A, B). Proliferation was 
found to reach a plateau after 3 weeks of culture when using cells from only one donor (Fig 3 
A). Although starting with comparable cell numbers per estimated surface areas at the time of 
seeding, monolayer cultured chondrocytes failed to increase their DNA content to the same 
extent as cells in microcarrier cultures until passage one (Fig 3 B). Consequently, the 
population doubling time of freshly isolated chondrocytes during the first two weeks of 
microcarrier culture was significantly shorter compared to cells cultured on TCP (p<0.01) 
(Fig 3 C). However, the growth rate of chondrocytes in monolayer cultures increased rapidly 
after the first passage (p<0.05). In contrast, the proliferation rate of adult chondrocytes in 
microcarrier cultures appeared to remain unchanged over 4 wks of in vitro propagation. Thus, 
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the time required for the cell population to double was significantly longer in microcarrier 
culture than in monolayer culture (p<0.05) over a culture period of four weeks. Accordingly, 
the yield of human articular chondrocytes cultivated in monolayer culture (population 
doublings: 8.12±0.26) was significantly greater than chondrocytes cultivated in microcarrier 
culture after 4 wks (population doublings: 4.11±0.75) (p<0.01). Donor age did not have any 
significant effect on cell growth or yields in both culture systems.  
Total collagen synthesis, assayed via the de novo incorporation of radio-labeled proline, 
decreased during culture, although this trend was not statistically significant (Fig 4 A). GAG 
associated with cells and extracellular matrix (relative to DNA) increased after the first week 
of microcarrier culture but thereafter declined (Fig 4 B). The majority of the GAG was 
detected in the spent culture medium (Fig 4 C). 
Redifferentiation potential after microcarrier and monolayer expansion 
The wet weight, DNA content and GAG per µg DNA, as determined by biochemical assays, 
did not change significantly for pellet differentiation cultures between day 7 and day 21 (Fig 5 
A-C). However, GAG secreted into the media of pellets increased significantly only in 
monolayer-cultivated cells (2D) after day 14 (p<0.05) and day 21 (p<0.01) (Fig 5 D). Cells 
adhered to microcarriers (MC+) continued to secrete GAG into media during differentiation, 
but did not retain GAG in their matrix (Fig 5 C,D). In contrast, substantial quantities of GAG 
accumulated in cell pellets formed without microcarriers (MC-, 2D). For these samples, the 
GAG in the extracellular matrix (ECM) correlated closely with GAG secreted into media 
(p<0.001) (Fig 5 E). Interestingly, no significant differences were observed in the wet weight, 
DNA and GAG content of pellets formed with cells expanded on tissue culture plastic (2D) or 
on microcarriers (MC-). Pellets containing microcarriers (MC+) were obviously larger and 
significantly heavier than pellets from the other two groups (p<0.001). However, MC+ 
samples contained significantly more DNA from the start of the experiment than 2D or MC- 
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groups (p<0.001). Large donor-related variations in cell behavior were observed. These 
differences were not correlated with donor age or the number of cell population doublings 
during expansion. While the pelleted cells from one donor were more densely packed from 
monolayer-expanded compared to microcarrier-expanded cultures (Fig 6 TCP, MC-), pellets 
from other donors showed the opposite trend (data not shown). Pellets from monolayer-
cultured cells exhibited weaker staining for GAG than cell pellets from microcarrier cultures. 
However, in contrast to microcarrier cultured cells, samples from monolayer cultures 
immunoreacted strongly with collagen type II. Sections from all cultures tested positive for 
collagen type I. Chondrocytes on microcarrier-cell pellets were observed to grow in multiple 
layers on the microcarrier surfaces (Fig 6 MC+). Although chondrocytes from all donors 
formed well-integrated matrix in the space between the microcarrier aggregates, the ECM did 
not stain positive for GAG but for collagen II and appeared to immunoreact strongly with 
collagen I antibodies.  
Discussion 
The aim of this study was to characterize the behavior of adult human articular chondrocytes 
propagated on gelatin-based microcarriers and to compare the chondrogenic potential of the 
microcarrier-cultivated cells with those expanded in monolayer culture. We found that 
chondrocytes attached to microcarriers can be cultured in a stirring bioreactor over more than 
four weeks with sustained high viability. While these results support previous studies (6, 9, 
19, 20), we have shown for the first time that freshly isolated human articular chondrocytes 
readily attach to microcarriers derived from collagen type I without requiring intermediate 
monolayer isolation and expansion.  
Based on our rough approximation of the surface area of the highly porous microcarriers, the 
DNA content / cell numbers normalized to estimated culture surface areas were higher in 
micocarrier than in monolayer cultures at week two (passage 1 of monolayer-cultured cells). 
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Population doubling times for the first 2 weeks of culture were shorter in microcarrier cultures 
compared to monolayer cultures. These observations may be explained by the fact that fewer 
cells initially attach to tissue culture plastic than to the microcarrier surface and/or that 
chondrocytes in monolayer culture enter a proliferative state later than chondrocytes attached 
to porous microcarriers. Frondoza et al. (9) reported high seeding efficiency (80%) of human 
osteoarthritic chondrocytes on bovine collagen microcarriers and a population doubling time 
of approximately 3.2 days after two weeks. This is shorter than we observed in our study (4.3 
days), which may have resulted from the fact that chondrocytes at passage 6 were used in 
Frondoza’s study. Thus, these cells may have already acquired a more dedifferentiated and, 
hence, proliferative state. Faster cell doublings have also been reported for human nasal 
chondrocytes on porous microcarriers (6, 19, 20). However, a direct comparison with our 
results is troublesome, since it has been demonstrated that monolayer-cultured nasoseptal 
cells proliferate 4 times faster than those of articular origin (11). 
The higher population doubling times and increased microcarrier aggregation in microcarrier-
cultured cells after 2-4 weeks observed in our studies indicate that cells reach confluence on 
the microcarrier surface, in contrast to TCP cultures where cells are reseeded at lower density 
during every passage. Aggregation could be desirable, as cellular bridging has been reported 
to be a mechanism by which cells can populate unoccupied microcarriers (21). The addition 
of extra microcarriers may therefore represent an option to sustain a faster rate of cell 
expansion in long-term microcarrier cultures (8). On the other hand, the reduction in 
population doubling time in cells cultivated on TCP after passage 1 relative to microcarrier 
cultures, suggests that cells more strongly dedifferentiate in conventional monolayer cultures 
by adopting a mesenchymal cell phenotype with increased proliferation capacity. 
Chondrocytes propagated in monolayers rapidly dedifferentiate (4) and acquire a spindle 
shaped morphology (22), reassembling their cytoskeleton into thick bundles of actin fibers 
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(23). Although a proportion of the cells in microcarrier cultures retained a round shape and 
did not transform into the dedifferentiated fibroblastic phenotype, we did observe a gradual 
decrease of the synthetic activity of the chondrocytes. Our study also indicates that despite the 
intended 3D environment, the cells resided mainly on the surface of the microcarriers and 
subsequently experienced a more 2D-like microenvironment. This might have contributed to 
the gradual dedifferentiation we observed during microcarrier expansion. 
The ultimate proof of chondrogenic potential requires a long-term differentiation study. While 
microcarrier- and monolayer-propagated cells retained their chondrogenic differentiation 
potential when cultured in micromass pellets using serum-free media, we could not confirm, 
however, if microcarrier cultures enhance the redifferentiation capacity of in vitro expanded 
human articular chondrocytes, as previously shown with nasoseptal chondrocytes (6). Indeed, 
the chondrogenic potential of the human articular chondrocytes we observed is markedly less 
than the capacity of chondrocytes from the nasal septum (11). Nevertheless, the finding of 
comparable chondrogenic potential is surprising, as the microcarrier-expanded chondrocytes 
underwent significantly fewer population doublings than monolayer-expanded cells. This 
raises the question of whether the prolonged proliferation, and in turn increased cellular 
senescence, or the duration of exposure to the artificial in vitro environment is the critical 
factor for chondrocyte dedifferentiation.  
Chondrocytes that remained attached to microcarriers failed to differentiate under 
chondrogenic culture conditions. The highly cellularized tissue formed in these pellets tested 
negative for GAG and exhibited strong immunoreactivity for the fibroblast protein, collagen 
type I. In contrast, the same cells, when enzymatically released from the carrier and 
subsequently differentiated in pellet culture, were able to incorporate GAG in their 
extracellular matrix. This observation is consistent with a recently published study in which 
osteoarthritic chondrocytes cultured on gelatin microcarriers and encapsulated in blood 
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plasma-derived glues also failed to form sufficient cartilaginous ECM (24). This suggests that 
the gelatin-derived microcarrier matrix had an inhibitory effect on chondrogenesis. The 
underlying mechanism, however, remains unclear and could be further investigated by 
comparing cells cultivated either on TCP, gelatin-coated TCP or gelatin microcarriers. 
Individual donors had a significant influence on the outcome of our study. Articular 
chondrocytes from human donors can exhibit substantial differences in chondrogenic 
potential (11, 25). Contributing factors include the patients’ genetic predispositions and, of 
course, diverse medical histories. Despite the small sample size of our study, it is clear that 
individual adult human articular chondrocytes respond diversly to microcarrier expansion. 
Thus, if such an expansion approach is to be adopted clinically, a screening process based on 
chondrogenic differentiation markers, such as that currently successfully used for autologous 
chondrocyte implantation procedures (26), is recommended. 
In conclusion, we have demonstrated that freshly-isolated adult human articular chondrocytes 
can be successfully propagated on gelatin-microcarriers. Nevertheless, further studies are 
required to substantiate the advantages of microcarrier cultivation over conventional 
monolayer expansion. In this regard, microcarriers derived from different materials and/or 
coated with different proteins could be tested. Human articular chondrocytes show only 
limited chondrogenic potential in basic pellet differentiation models; therefore, additional 
parameters, such as oxygen tension and mechanical stimulation, should be optimized to 
improve redifferentiation of human articular chondrocytes. It remains to be determined why 
gelatin-microcarriers prevent the differentiation of chondrocytes in situ.  
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Figure legends 
 
Figure 1: Human articular chondrocytes in microcarrier culture: A+D+G: day 2, B+E+H: day 
15, C+F+I: day 30. A-C: phase contrast microscopy; D-F: live-dead staining (cells living: 
green, dead: red); G-I: MTT staining (metabolically active cells: purple). Scale bars 100 μm. 
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Figure 2: Human articular chondrocytes cultivated on glass slides (A, B) and on microcarriers 
(C-E). A-C: 1 week, D+E: 2 weeks (actin filaments: red, cell nuclei: blue). Scale bars 100 μm. 
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Figure 3: DNA content (A) in microcarrier cultures of human chondrocytes (mean + or - SD, 
n≥2). DNA content normalized to surface areas (B) and population doubling times (C) of 
chondrocytes in monolayer (TCP) or in microcarrier culture (MC) over 2 or 4 weeks. Mean 
±SD, n≥3 (donors), † = p<0.05, ‡ = p<0.01. 
E 
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Figure 4: L-[5-
3
H]-proline (A) and GAG content of cells/ECM (B) and conditioned media (C) 
from human articular chondrocytes in microcarrier culture. Mean ± SD, n≥2. 
Microcarrier-expansion of human articular chondrocytes 
22 
 
Figure 5: Wet weight (A), DNA (B) and GAG content of cells/ECM (C) and conditioned 
media (D) from pellet differentiation cultures of human chondrocytes expanded on tissue 
culture plastic (2D) or on microcarriers (MC-). Pellets were also made using microcarriers 
with attached cells (MC+). Mean ± SE, n=3 (donors), † = p<0.05, ‡ = p<0.01. Correlation (E) 
of GAG found in pellets and in conditioned media during differentiation of cells from 
microcarrier (♦) and monolayer (▲) cultures. 
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Figure 6: Immunohistochemistry for collagen type II and type I and histology for 
glycosaminoglycans (GAG)of pellet differentiation cultures of human chondrocytes expanded 
on tissue culture plastic (TCP) or on microcarriers (MC- and MC+) after 21 days. Arrows 
identify microcarriers in pellets formed using microcarriers with attached cells (MC+). 
Collagen type II and I: brown. Safranin O: red (GAG), Fast Green: cyan, (ECM) and 
hematoxylin: purple (nuclei). Scale bars 100 μm. 
 
